Patent · US Active

Method for treating a pulmonary hypertension condition

US9474752B2 · kind B2 · utility

0Cited by
15References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 17, 2014
Grant dateOct 25, 2016
Priority date
Expiry dateFeb 17, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension (PAH) in a subject comprises administering to the subject a therapeutically effective amount of ambrisentan, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.